About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Key Takeaways PM's smoke-free portfolio made up 44% of gross profit in Q1, hitting a key transition milestone. PM's smoke-free gross margin surpassed 70%, over 5 percentage points above combustible products. Smoke-free gross profit rose 33% YoY, outpacing volume gains and boosting operating income margin.Philip Morris International (PM) is redefining its profit engine through the accelerated growth of the smoke-free portfolio. In the first quarter of 2025, smoke-free products contributed 44% of the compan ...

Key Takeaways BMY's legacy portfolio revenues fell 20% in Q1, hit by generics and Medicare Part D redesign. Revlimid, Pomalyst, Sprycel and Abraxane all saw double-digit sales declines from generic competition. Eliquis dropped 4%, but BMY expects recovery in H2 2025 as Medicare coverage gap is eliminated.Bristol Myers’ (BMY) legacy portfolio comprises Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane.Revenues for the Legacy Portfolio plunged 20% in the first quarter to $5.64 billion due to the continued g ...

Key Takeaways Posco plans a U.S. lithium pilot plant with Anson Resources to test its Direct Lithium Extraction technology. PKX targets reducing dependence on Chinese suppliers to comply with new U.S. import restrictions. PKX aims to commercialize its DLE technology across North America's untapped lithium brine resources.Posco Holdings (PKX) has announced plans to develop a trial lithium processing plant in the United States in collaboration with Australia's Anson Resources. This is in sync with the compa ...

Core Insights - Taiwan Semiconductor Manufacturing Company (TSMC) shares reached a 52-week high of $233.82, closing at $233.60, with an 18.2% year-to-date (YTD) increase, outperforming the Zacks Computer and Technology sector's 5.6% rise [1][10] - TSMC has outperformed peers such as NVIDIA, Advanced Micro Devices, and Intel, which saw YTD increases of 17%, 14.6%, and 9.1%, respectively [2][10] - Investor confidence in TSMC's long-term prospects is growing, supported by strong fundamentals and a favorable long-term outlook [3] Financial Performance - In the first quarter of 2025, TSMC reported a 35% year-over-year revenue increase to $25.53 billion and a 53% rise in net income to nearly $11 billion [8] - The company's earnings per share (EPS) jumped 53.6% to $2.12, exceeding the Zacks Consensus Estimate of $2.03, with an average surprise of 6.9% over the last four quarters [9] AI-Driven Growth - AI-related revenues for TSMC tripled in 2024, contributing a mid-teen percentage to total revenues, with expectations to double again in 2025 and a projected 40% compound annual growth rate over the next five years [7][10] - TSMC is positioned as a key player in the AI revolution, supplying advanced chips to major companies like NVIDIA and AMD [6] Investment and Valuation - TSMC plans to invest between $38 billion and $42 billion in capital expenditures in 2025, significantly higher than the $29.8 billion investment in 2024, with 70% of this focused on advanced manufacturing processes [11] - The Zacks Consensus Estimate predicts revenue growth of 29.8% and 17.3% for 2025 and 2026, respectively, with EPS expected to rise by 31.8% and 15.8% [12] - TSMC's forward 12-month price-to-earnings (P/E) ratio is 23.32X, lower than the sector average of 26.7, making it an attractive option for long-term investors [13][14] Conclusion - TSMC's dominance in advanced nodes, increasing AI-related demand, and aggressive capacity investments position it well for future growth, making it a compelling buy opportunity [15]

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Gray Media (GTN) .Gray Media currently has an average brokerage r ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about MicroStrategy (MSTR) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.MicroStrategy currently has an averag ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about AbbVie (ABBV) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.AbbVie currently has an average brokerage recommendation (ABR) of ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Visa (V) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Visa currently has an average brokerage ...

NASHVILLE, Tenn., July 3, 2025 /PRNewswire/ -- AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that Second Quarter 2025 financial and operating results will be released before the market opens on Thursday, July 24, 2025. Management will conduct a teleconference beginning at 9:00 am (CT), to discuss the results. The call will be hosted by Seth Bernstein, President and Chief Executive Officer; Thomas Simeone, Chief Financial Officer; and Onur Erzan, Head of Global Client G ...